{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:45Z","timestamp":1793158065466,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_2743"],"award-info":[{"award-number":["KYCX25_2743"]}]},{"name":"National Natural Science Foundation of China","award":["82171429"],"award-info":[{"award-number":["82171429"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01572-8","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:42:48Z","timestamp":1784284968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Secretory leukocyte protease inhibitor (SLPI) attenuates TLR4\/NF-\u03baB-mediated neuroinflammation in amyotrophic lateral sclerosis: a candidate molecule associated with neuro-pathology"],"prefix":"10.1186","volume":"32","author":[{"given":"Ming-An","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Meng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-2827","authenticated-orcid":false,"given":"Wei-Jiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-4135","authenticated-orcid":false,"given":"Yan-Qin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"1572_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-9255-8-5","volume":"8","author":"VJ Adapala","year":"2011","unstructured":"Adapala VJ, Buhman KK, Ajuwon KM. Novel anti-inflammatory role of SLPI in adipose tissue and its regulation by high fat diet. J Inflamm (Lond). 2011;8:5.","journal-title":"J Inflamm (Lond)"},{"key":"1572_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12964-022-01036-6","volume":"21","author":"J Chang","year":"2023","unstructured":"Chang J, et al. Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury. Cell Commun Signal. 2023;21:37.","journal-title":"Cell Commun Signal"},{"key":"1572_CR22","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1159\/000492653","volume":"48","author":"PC Chen","year":"2018","unstructured":"Chen PC, Ruan JS, Wu SN. Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid-Induced Differentiation in Motor Neuron-Like NSC-34 Cells. Cell Physiol Biochem. 2018;48:2374\u201388.","journal-title":"Cell Physiol Biochem"},{"key":"1572_CR11","doi-asserted-by":"crossref","unstructured":"Cihankaya H, et al. Elevated NLRP3 inflammasome activation is associated with motor neuron degeneration in ALS. Cells. 2024;13(12):995.","DOI":"10.3390\/cells13120995"},{"key":"1572_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.23728","volume":"68","author":"V Deora","year":"2020","unstructured":"Deora V, et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407\u201321.","journal-title":"Glia"},{"key":"1572_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41582-024-01049-4","volume":"21","author":"KME Faller","year":"2025","unstructured":"Faller KME, Chaytow H, Gillingwater TH. Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis. Nat Rev Neurol. 2025;21:86\u2013102.","journal-title":"Nat Rev Neurol"},{"key":"1572_CR15","doi-asserted-by":"crossref","unstructured":"Figueroa-Romero C, et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech. 2019;13(2):dmm041947.","DOI":"10.1242\/dmm.041947"},{"key":"1572_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awp304","volume":"133","author":"N Ghasemlou","year":"2010","unstructured":"Ghasemlou N, et al. Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury. Brain. 2010;133:126\u201338.","journal-title":"Brain"},{"key":"1572_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mcn.2018.11.002","volume":"94","author":"S Grottelli","year":"2019","unstructured":"Grottelli S, et al. Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells. Mol Cell Neurosci. 2019;94:23\u201331.","journal-title":"Mol Cell Neurosci"},{"key":"1572_CR8","doi-asserted-by":"crossref","unstructured":"Guttenplan KA, et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11(1):3753.","DOI":"10.1038\/s41467-020-17514-9"},{"key":"1572_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000047744","volume":"13","author":"J Ilzecka","year":"2002","unstructured":"Ilzecka J, Stelmasiak Z. Increased serum levels of endogenous protectant secretory leukocyte protease inhibitor in acute ischemic stroke patients. Cerebrovasc Dis. 2002;13:38\u201342.","journal-title":"Cerebrovasc Dis"},{"key":"1572_CR28","doi-asserted-by":"crossref","unstructured":"Jin FY, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 1997;88(3):417\u201326.","DOI":"10.1016\/S0092-8674(00)81880-2"},{"key":"1572_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12974-015-0310-z","volume":"12","author":"JY Lee","year":"2015","unstructured":"Lee JY, Lee JD, Phipps S, Noakes PG, Woodruff TM. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2015;12:90.","journal-title":"J Neuroinflammation"},{"key":"1572_CR29","doi-asserted-by":"crossref","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","DOI":"10.1038\/nature21029"},{"key":"1572_CR26","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1093\/hmg\/ddt325","volume":"22","author":"E Lilo","year":"2013","unstructured":"Lilo E, et al. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model. Hum Mol Genet. 2013;22:4720\u20135.","journal-title":"Hum Mol Genet"},{"key":"1572_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/NRR.NRR-D-23-01904","volume":"20","author":"I Martinelli","year":"2025","unstructured":"Martinelli I, et al. Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence? Neural Regen Res. 2025;20:130\u20138.","journal-title":"Neural Regen Res"},{"key":"1572_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22:185\u2013212.","journal-title":"Nat Rev Drug Discov"},{"key":"1572_CR30","doi-asserted-by":"crossref","unstructured":"Mongkolpathumrat P, et al. Anti-protease activity deficient Secretory Leukocyte Protease Inhibitor (SLPI) exerts cardioprotective effect against myocardial ischaemia\/reperfusion. Biomedicines. 2022;10(5):988.","DOI":"10.3390\/biomedicines10050988"},{"key":"1572_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"T Philips","year":"2011","unstructured":"Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253\u201363.","journal-title":"Lancet Neurol"},{"key":"1572_CR21","doi-asserted-by":"publisher","first-page":"113938","DOI":"10.1016\/j.intimp.2024.113938","volume":"146","author":"CM Qiao","year":"2025","unstructured":"Qiao CM, et al. Mechanism of S100A9-mediated astrocyte activation via TLR4\/NF-kappaB in Parkinson\u2019s disease. Int Immunopharmacol. 2025;146:113938.","journal-title":"Int Immunopharmacol"},{"key":"1572_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1600-6143.2008.02158.x","volume":"8","author":"S Schneeberger","year":"2008","unstructured":"Schneeberger S, et al. The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia\/reperfusion injury in cardiac transplantation. Am J Transpl. 2008;8:773\u201382.","journal-title":"Am J Transpl"},{"key":"1572_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1042\/BST0391437","volume":"39","author":"A Scott","year":"2011","unstructured":"Scott A, Weldon S, Taggart CC. SLPI and elafin: multifunctional antiproteases of the WFDC family. Biochem Soc Trans. 2011;39:1437\u201340.","journal-title":"Biochem Soc Trans"},{"key":"1572_CR24","doi-asserted-by":"crossref","unstructured":"Suh HS, Choi N, Tarassishin L, Lee SC. Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PLoS One. 2012;7(4):e35115.","DOI":"10.1371\/journal.pone.0035115"},{"key":"1572_CR7","doi-asserted-by":"publisher","first-page":"110760","DOI":"10.1016\/j.brainresbull.2023.110760","volume":"202","author":"J Tang","year":"2023","unstructured":"Tang J, et al. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Res Bull. 2023;202:110760.","journal-title":"Brain Res Bull"},{"key":"1572_CR4","doi-asserted-by":"crossref","unstructured":"Van Harten ACM, Phatnani H, Przedborski S. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. 2021;44(8): 658\u201368.","DOI":"10.1016\/j.tins.2021.04.008"},{"key":"1572_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/NRR.NRR-D-24-00034","volume":"21","author":"G Vitale","year":"2026","unstructured":"Vitale G, Amadio S, Liguori F, Volonte C. Empowering the NSC-34 cell line as a motor neuron model: Cytosine arabinoside\u2019s action. Neural Regen Res. 2026;21:357\u201364.","journal-title":"Neural Regen Res"},{"key":"1572_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/mol.64.4.833","volume":"64","author":"X Wang","year":"2003","unstructured":"Wang X, et al. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol Pharmacol. 2003;64:833\u201340.","journal-title":"Mol Pharmacol"},{"key":"1572_CR1","doi-asserted-by":"publisher","first-page":"116496","DOI":"10.1016\/j.ejmech.2024.116496","volume":"272","author":"Y Wei","year":"2024","unstructured":"Wei Y, et al. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies. Eur J Med Chem. 2024;272:116496.","journal-title":"Eur J Med Chem"},{"key":"1572_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbi.2025.04.001","volume":"128","author":"J Wu","year":"2025","unstructured":"Wu J, et al. Gut microbiota promote the propagation of pathologic alpha-syn from gut to brain in a gut-originated mouse model of Parkinson\u2019s disease. Brain Behav Immun. 2025;128:152\u201369.","journal-title":"Brain Behav Immun"},{"key":"1572_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-025-00477-6","volume":"14","author":"Q Xie","year":"2025","unstructured":"Xie Q, et al. Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients. Transl Neurodegener. 2025;14:19.","journal-title":"Transl Neurodegener"},{"key":"1572_CR14","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1007\/s12035-024-03988-x","volume":"61","author":"Z Xin","year":"2024","unstructured":"Xin Z, et al. Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1(G93A) Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis. Mol Neurobiol. 2024;61:10051\u201371.","journal-title":"Mol Neurobiol"},{"key":"1572_CR32","doi-asserted-by":"crossref","unstructured":"Xu W, et al. A novel immune modulator IM33 mediates a glia-gut-neuronal axis that controls lifespan. Neuron. 2023;111(20): 3244\u201354.e3248.","DOI":"10.1016\/j.neuron.2023.07.010"},{"key":"1572_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.immuni.2025.02.024","volume":"58","author":"M Zelic","year":"2025","unstructured":"Zelic M, et al. Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis. Immunity. 2025;58:961\u201379. e968.","journal-title":"Immunity"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01572-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01572-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01572-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:02:04Z","timestamp":1791910924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01572-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01572-8","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Jiangnan University Institutional Animal Care and Use Committee (approval no. JN. No 20231230m0090715[618]). The study is reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"184"}}